These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 29523813)

  • 21. Heterogeneity of prostate-specific membrane antigen (PSMA) expression in prostate carcinoma with distant metastasis.
    Mannweiler S; Amersdorfer P; Trajanoski S; Terrett JA; King D; Mehes G
    Pathol Oncol Res; 2009 Jun; 15(2):167-72. PubMed ID: 18802790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiparametric MRI in detection and staging of prostate cancer.
    Boesen L
    Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening and identification of significant genes related to tumor metastasis and PSMA in prostate cancer using microarray analysis.
    Xu L; Wang Z; Li XF; He X; Guan LL; Tuo JL; Wang Y; Luo Y; Zhong HL; Qiu SP; Cao KY
    Oncol Rep; 2013 Oct; 30(4):1920-8. PubMed ID: 23917490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PGC and PSMA in prostate cancer diagnosis: tissue analysis from biopsy samples.
    Antunes AA; Reis ST; Leite KR; Real DM; Sousa-Canavez JM; Camara-Lopes LH; Dall'Oglio MF; Srougi M
    Int Braz J Urol; 2013; 39(5):649-56. PubMed ID: 24267108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Performance of different prostate specific antibodies in the cytological diagnosis of metastatic prostate adenocarcinoma.
    Jia L; Jiang Y; Michael CW
    Diagn Cytopathol; 2017 Nov; 45(11):998-1004. PubMed ID: 28888085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers.
    Wernicke AG; Varma S; Greenwood EA; Christos PJ; Chao KS; Liu H; Bander NH; Shin SJ
    APMIS; 2014 Jun; 122(6):482-9. PubMed ID: 24304465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prospective randomized multicentre study of the impact of gallium-68 prostate-specific membrane antigen (PSMA) PET/CT imaging for staging high-risk prostate cancer prior to curative-intent surgery or radiotherapy (proPSMA study): clinical trial protocol.
    Hofman MS; Murphy DG; Williams SG; Nzenza T; Herschtal A; Lourenco RA; Bailey DL; Budd R; Hicks RJ; Francis RJ; Lawrentschuk N
    BJU Int; 2018 Nov; 122(5):783-793. PubMed ID: 29726071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation and comparison of two new prostate carcinoma markers. Free-prostate specific antigen and prostate specific membrane antigen.
    Murphy GP; Barren RJ; Erickson SJ; Bowes VA; Wolfert RL; Bartsch G; Klocker H; Pointner J; Reissigl A; McLeod DG; Douglas T; Morgan T; Kenny GM; Ragde H; Boynton AL; Holmes EH
    Cancer; 1996 Aug; 78(4):809-18. PubMed ID: 8756376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of circulating prostate cells during radical prostatectomy by standardized PSMA RT-PCR: association with positive lymph nodes and high malignant grade.
    Schmidt B; Anastasiadis AG; Seifert HH; Franke KH; Oya M; Ackermann R
    Anticancer Res; 2003; 23(5A):3991-9. PubMed ID: 14666708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of two gene panels for prostate cancer diagnosis and patient risk stratification.
    Xiao K; Guo J; Zhang X; Feng X; Zhang H; Cheng Z; Johnson H; Persson JL; Chen L
    Tumour Biol; 2016 Aug; 37(8):10115-22. PubMed ID: 26820133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel regulation of PSMA and PSA expression by Q640X AR in 22Rv1 and LNCaP prostate cancer cells.
    Ben Jemaa A; Sallami S; Céraline J; Oueslati R
    Cell Biol Int; 2013 May; 37(5):464-70. PubMed ID: 23418075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N-acetyl-L-aspartyl-L-glutamate peptidase-like 2 is overexpressed in cancer and promotes a pro-migratory and pro-metastatic phenotype.
    Whitaker HC; Shiong LL; Kay JD; Grönberg H; Warren AY; Seipel A; Wiklund F; Thomas B; Wiklund P; Miller JL; Menon S; Ramos-Montoya A; Vowler SL; Massie C; Egevad L; Neal DE
    Oncogene; 2014 Nov; 33(45):5274-87. PubMed ID: 24240687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of combined "triple"-reverse transcription-PCR analysis for prostate-specific antigen, human kallikrein 2, and prostate-specific membrane antigen mRNA in peripheral blood and lymph nodes of prostate cancer patients.
    Kurek R; Nunez G; Tselis N; Konrad L; Martin T; Roeddiger S; Aumüller G; Zamboglou N; Lin DW; Tunn UW; Renneberg H
    Clin Cancer Res; 2004 Sep; 10(17):5808-14. PubMed ID: 15355910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models.
    Denmeade SR; Sokoll LJ; Dalrymple S; Rosen DM; Gady AM; Bruzek D; Ricklis RM; Isaacs JT
    Prostate; 2003 Mar; 54(4):249-57. PubMed ID: 12539223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of prostate specific membrane antigen by canine hemangiosarcoma cells provides opportunity for the molecular detection of disease burdens within hemorrhagic body cavity effusions.
    Dowling M; Samuelson J; Fadl-Alla B; Pondenis HC; Byrum M; Barger AM; Fan TM
    PLoS One; 2019; 14(1):e0210297. PubMed ID: 30601866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic Performance of Radiolabeled Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Primary Lymph Node Staging in Newly Diagnosed Intermediate to High-Risk Prostate Cancer Patients: A Systematic Review and Meta-Analysis.
    Kim SJ; Lee SW; Ha HK
    Urol Int; 2019; 102(1):27-36. PubMed ID: 30269140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biochemical characterization of prostate-specific membrane antigen from canine prostate carcinoma cells.
    Wu LY; Johnson JM; Simmons JK; Mendes DE; Geruntho JJ; Liu T; Dirksen WP; Rosol TJ; Davis WC; Berkman CE
    Prostate; 2014 May; 74(5):451-7. PubMed ID: 24449207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insight into the heterogeneity of prostate cancer through PSA-PSMA prostate clones: mechanisms and consequences.
    Ben Jemaa A; Bouraoui Y; Oueslati R
    Histol Histopathol; 2014 Oct; 29(10):1263-80. PubMed ID: 24788382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic Accuracy of
    Cantiello F; Gangemi V; Cascini GL; Calabria F; Moschini M; Ferro M; Musi G; Butticè S; Salonia A; Briganti A; Damiano R
    Urology; 2017 Aug; 106():139-145. PubMed ID: 28438628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation of primary tumor prostate-specific membrane antigen expression with disease recurrence in prostate cancer.
    Ross JS; Sheehan CE; Fisher HA; Kaufman RP; Kaur P; Gray K; Webb I; Gray GS; Mosher R; Kallakury BV
    Clin Cancer Res; 2003 Dec; 9(17):6357-62. PubMed ID: 14695135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.